AGP Executive Report
Last update: 12 hours agoPrenatal Testing Breakthrough (Sweden/Europe): A new non-invasive fetal sequencing approach (NIFS) presented in Gothenburg can screen nearly 23,000 genes from a maternal blood sample, aiming to match invasive genome sequencing while avoiding procedure-related risks. Mental Health (Sweden): Lund University and Region Skåne report that pramipexole, a Parkinson’s drug, may help depression patients with severe anhedonia as an add-on therapy. Hematology Updates (EHA 2026): Multiple studies highlight progress in blood cancers, including safer dose-reduced regimens for frail/older DLBCL patients and durable responses in lower-risk MDS with luspatercept. Privacy & Tech (EU): Regulators are ramping up scrutiny of smart glasses after concerns about consent and personal data capture, with Swedish reporting cited in the debate. Maternal Health Access (EU visas): Midwifery experts from parts of Africa and Asia, including Bangladeshis, were denied visas for a Portugal conference, threatening progress on reducing pregnancy and childbirth deaths. Public Health Policy (Canada): Canada proposes stricter rules for social media access for kids under 16, including a new digital regulator and penalties for unsafe platforms.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
![<![CDATA[Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis]]>](https://cdn.sanity.io/images/0vv8moc6/onclive/7903a3b45d4ca9f9ca23da540e0dcd792904bcc0-1280x720.jpg)
